Navigation Links
Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
Date:7/27/2009

Los Angeles, London, New Delhi, Singapore and Washington DC (July 27, 2009) According to a study in a special issue of Medical Decision Making, a large-scale, covert anthrax attack on a large city would overwhelm hospital resources even with an extremely effective public health response, primarily because of expected delays in detecting the attack and initiating a response to it.

The article "Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations," examines one of the CDC's principal bioterrorism-response programs, the Cities Readiness Initiative (CRI), a program that recommends the medical countermeasures necessary to minimize the hospital surge resulting from anthrax-related illness and response in the first two days after a major bioterrorism attack.

The researchers found that a CRI-compliant prophylaxis campaign starting two days after exposure would protect as many as 86% of exposed individuals from illness. However, each additional day needed to complete the campaign would result in as much as 3% more hospitalizations in the exposed population. Unsustainable levels of hospitalizations would result from delays in detecting and initiating response to large-scale, covert aerosol anthrax releases in a major city, even with highly effective mass prophylaxis campaigns.

The article, written by Nathaniel Hupert, incorporates some of the latest type of modeling techniques scientists use in the disaster preparedness.field. Such models have become increasingly important to public health officials and hospital administrators. To improve the consistency and quality of these models, the Society for Medical Decision Making convened experts to recommend best practices for modeling the public health response to a terror attack. Their article, also published in the current issue of Medical Decision Making, is entitled

    <
    '/>"/>


Contact: Jim Gilden
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

Page: 1 2

Related biology news :

1. Defying the disaster: Researcher explores resilient housing
2. Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters
3. International Council for Science launches major research program on natural disasters
4. Looming tropical disaster needs urgent action
5. Killer fungus spells disaster for wheat
6. Triage study challenges notions of emergency medical response to disaster
7. Soil, conservation experts to reflect on Hurricane Katrina disaster
8. Researchers find evidence linking stress caused by the Sept. 11 disaster with low birth weights
9. ORNL resilience plan to help Tennessee, Mississippi and South Carolina communities beat disaster
10. Security preparedness at federally managed dams
11. Unexplored Arctic region to be mapped
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... a unique vulnerability that can be exploited to make ... Washington University School of Medicine in St. Louis report. ... that tumors have a built-in mechanism that protects them ... benefit of hyperthermia and radiation as a combined therapy. ...
... way to rejuvenate dead nerve endings and a device ... among this years nine winners at NJITs annual provosts ... I walk through this showcase is the sophisticated array ... undergraduate students, said NJIT Provost Priscilla P. Nelson. ...
... the US, many people believe that the recent proliferation of ... people aim to significantly reduce the amount of saturated fats ... healthier, and happier. However, many leading researchers in the medical ... In FAT: ITS NOT WHAT YOU THINK (Prometheus, $15.95), technical ...
Cached Biology News:Researchers find way to make tumor cells easier to destroy 2NJIT applauds students for studies on brain injury, glaucoma and more 2Fat: Its not what you think! 2
(Date:12/24/2014)... and NEW YORK , ... from its open-label pilot study of mazindol in children ... Development and Therapy in December 2014 . ... mazindol in children with attention deficit/hyperactivity disorder" ( Konofal ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) shows ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... 2014 ITRA Global, one of the ... commercial real estate, has further expanded its global reach ... and Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman ... ITRA Global / ACORPP (Australian Corporate Property and Projects) ... providing property services to a wide range of clients ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the nation’s ... Pharm.D. to the newly created position of Vice President ... Dr. Maroulis will continue to manage the entire specialty ... pharmacies as the company expands. Dr. Maroulis has been ... has served in many different capacities in the pharmacy, ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... 19 The 2009 Frost & Sullivan European ... Xenometrix AG in recognition of its active role ... cytotoxicity assays. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )These test ... drug discovery, improve the effectiveness of drug discovery ...
... sail to Baltic, Black and Mediterranean Seas, sampling ... local San Diego supporters Beyster Family Foundation Fund ... DIEGO, March 18, The J. Craig Venter ... new Sorcerer II Expedition--the J. Robert Beyster and ...
... Pharmatech Oncology has been selected by the Fitzsimons ... Colorado Science + Technology Park at Fitzsimons. The ... companies. The majority of the companies are in ... expanding their research on commercial products. Pharmatech Oncology ...
Cached Biology Technology:Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 2Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 3Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition 2Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition 3Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition 4Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition 5The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor 2
... 384 Round Well ... Thermo Labsystems wide range ... ideal for high-throughput screening ... miniaturization of assays and ...
HLA-DRbeta (DA2)...
...
Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)...
Biology Products: